Maria Alessio Selected Research

Maria Alessio Research Topics

Disease

11	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2022 - 07/2004
6	Uveitis 08/2021 - 06/2010
4	Cryopyrin-Associated Periodic Syndromes 02/2013 - 09/2007
3	Pain (Aches) 12/2019 - 08/2008
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2013 - 06/2006
2	Pericarditis 06/2014 - 02/2014
2	Localized Scleroderma (Morphea) 12/2012 - 07/2011
1	Disease Progression 04/2022
1	Fever (Fevers) 10/2021
1	Inflammation (Inflammations) 06/2021
1	Familial Mediterranean Fever (Periodic Disease) 01/2021
1	Adult-Onset Still's Disease 01/2019
1	Injection Site Reaction 08/2018
1	Primary Hypertrophic Osteoarthropathy (Hypertrophic Osteoarthropathy, Primary) 01/2018
1	Arthralgia (Joint Pain) 01/2018
1	Necrosis 10/2017
1	Skin Manifestations 10/2017
1	Splenomegaly 10/2017
1	Chorea (Rheumatic Chorea) 01/2017
1	Osteomyelitis 07/2016
1	Left Ventricular Dysfunction 02/2015
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 02/2015
1	Insulin Resistance 02/2015
1	Cataract (Cataracts) 04/2014
1	Joint Diseases (Joint Disease) 02/2014
1	Coxa Vara 02/2014
1	Anterior Uveitis 06/2013
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 09/2012
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 09/2012
1	Venous Thrombosis (Deep-Vein Thrombosis) 09/2012
1	Hyponatremia 09/2012
1	Thrombocytopenia (Thrombopenia) 09/2012
1	Anemia 09/2012
1	Polyarteritis Nodosa (Periarteritis Nodosa) 07/2012
1	Arthritis (Polyarthritis) 02/2012
1	Body Weight (Weight, Body) 02/2005
1	Cryoglobulinemia 02/2003
1	Chronic Hepatitis C 02/2003
1	Infections 02/2003

Drug/Important Bio-Agent (IBA)

4	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2019 - 09/2007
3	Interleukin-1 (Interleukin 1)IBA 01/2018 - 09/2007
3	Biological ProductsIBA 01/2018 - 09/2007
3	Abatacept (Orencia)FDA Link 11/2016 - 06/2010
3	Methotrexate (Mexate)FDA LinkGeneric 12/2012 - 07/2004
2	canakinumab FDA Link 11/2022 - 02/2013
2	Colchicine FDA LinkGeneric 01/2021 - 06/2014
2	InterleukinsIBA 01/2019 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2018
2	Immunosuppressive Agents (Immunosuppressants)IBA 08/2018 - 07/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2016 - 06/2010
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 06/2014 - 09/2007
1	Etanercept (Enbrel)FDA Link 10/2021
1	Antinuclear AntibodiesIBA 08/2021
1	Opioid Analgesics (Opioids)IBA 12/2019
1	Acetaminophen (Paracetamol)FDA LinkGeneric 12/2019
1	Ibuprofen (Motrin)FDA LinkGeneric 12/2019
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2018
1	Thalidomide (Thalomid)FDA Link 10/2017
1	Adenosine DeaminaseIBA 10/2017
1	Fibrinogen (Factor I)FDA Link 10/2017
1	Hemoglobins (Hemoglobin)IBA 10/2017
1	hexamethylpropyleneamine oximeIBA 01/2017
1	Diphosphonates (Bisphosphonates)IBA 07/2016
1	Insulin (Novolin)FDA Link 02/2015
1	GlucocorticoidsIBA 02/2015
1	Testosterone (Sustanon)FDA Link 02/2015
1	Gonadal Steroid Hormones (Sex Hormones)IBA 02/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2014
1	MucinsIBA 02/2014
1	Glycoproteins (Glycoprotein)IBA 02/2014
1	LubricantsIBA 02/2014
1	Proteoglycans (Proteoglycan)IBA 02/2014
1	Adalimumab (Humira)FDA Link 06/2013
1	Antiphospholipid AntibodiesIBA 09/2012
1	DNA (Deoxyribonucleic Acid)IBA 09/2012
1	AntibodiesIBA 09/2012
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 07/2012
1	InflammasomesIBA 01/2011
1	ametantrone (HAQ)IBA 08/2008
1	Interleukin-1beta (Interleukin 1 beta)IBA 09/2007
1	SuspensionsIBA 02/2005
1	Meloxicam (Mobic)FDA LinkGeneric 02/2005
1	Naproxen (Naprosyn)FDA LinkGeneric 02/2005
1	InterferonsIBA 02/2003

Therapy/Procedure

9	Therapeutics 04/2022 - 02/2003
1	Slit Lamp 06/2021
1	Transitional Care 11/2019
1	Intraocular Lenses (Intraocular Lens) 04/2014
1	Intraocular Lens Implantation 04/2014
1	Aftercare (After-Treatment) 06/2010